Voyager Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Voyager Therapeutics

09/05/2023 14:33

* Voyager Therapeutics Inc  VYGR.OQ  reported quarterly
adjusted
earnings of $2.94​​ per share for the quarter ended in March.
The mean expectation of seven analysts for the quarter was
for earnings of 77 cents per share.
    * Revenue rose 22,769.3% to $150.48 million from a year ago;
analysts expected $41.00 million. 
    * Voyager Therapeutics Inc's reported EPS for the quarter
was
$2.94​.
    * The mean earnings estimate of analysts had fallen by
about 22.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Voyager Therapeutics Inc shares had risen by 7.8% this
quarter and gained 36.2% so far this year.
    * The company reported quarterly net income of $124.04
million.
    * Wall Street's median 12-month price target for Voyager
Therapeutics Inc is $10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
9 at 01:33 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      0.77           2.94           Beat
 Dec. 31 2022      -0.55          -0.61          Missed
 Sep. 30 2022      -0.32          0.45           Beat
 Jun. 30 2022      -0.32          -0.50          Missed